| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ANTEOTECH LTD: Collaborative New Immunoassay Product Development Program | - | ASX | ||
| Mo | AnteoTech H1 FY2026: Kostensenkungen greifen, doch Umsatzverschiebungen belasten die Bilanz | 1 | Investing.com Deutsch | ||
| Mo | AnteoTech H1 FY2026 slides: cost cuts deliver amid revenue timing delays | 1 | Investing.com | ||
| So | ANTEOTECH LTD: Half Year Results and Operational Update Presentation | - | ASX | ||
| ANTEOTECH Aktie jetzt für 0€ handeln | |||||
| 24.02. | ANTEOTECH LTD: Half Yearly Report and Accounts | - | ASX | ||
| 19.02. | ANTEOTECH LTD: Updated - Investor Webinar and Half Yearly Results Timing | 2 | ASX | ||
| 17.02. | ANTEOTECH LTD: Investor Webinar and Half Yearly Results Timing | - | ASX | ||
| 09.02. | ANTEOTECH LTD: Update - Notification of cessation of securities - ADO | 1 | ASX | ||
| 09.02. | ANTEOTECH LTD: Notification of cessation of securities - ADO | 1 | ASX | ||
| 04.02. | ANTEOTECH LTD: Notification regarding unquoted securities - ADO | - | ASX | ||
| 04.02. | ANTEOTECH LTD: Cleansing Notice under section 708A | 1 | ASX | ||
| 04.02. | ANTEOTECH LTD: Application for quotation of securities - ADO | 1 | ASX | ||
| 30.01. | Anteotech Accelerates Battery and Life Sciences Commercialisation as Capital Raise Extends Runway | 3 | smallcaps.com.au | ||
| 29.01. | ANTEOTECH LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 27.01. | ANTEOTECH LTD: Appointment of Interim CFO and Company Secretary | - | ASX | ||
| 27.01. | AnteoTech Raises $3.5m for Global Commercialisation of Life Sciences and Advanced Battery Technologies | 3 | smallcaps.com.au | ||
| 27.01. | ANTEOTECH LTD: Proposed issue of securities - ADO | 1 | ASX | ||
| 27.01. | ANTEOTECH LTD: Proposed issue of securities - ADO | 2 | ASX | ||
| 27.01. | ANTEOTECH LTD: AnteoTech $3.5m Capital Raising | 1 | ASX | ||
| 21.01. | ANTEOTECH LTD: Trading Halt | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,680 | -10,34 % | EQS-Adhoc: Formycon AG veröffentlicht vorläufige Zahlen für das Geschäftsjahr 2025 | EQS-Ad-hoc: Formycon AG / Schlagwort(e): Geschäftszahlen / Gesamtjahr/Sonstiges
Formycon AG veröffentlicht vorläufige Zahlen für das Geschäftsjahr 2025
04.03.2026 / 22:50 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| GOMSPACE | 1,678 | -4,66 % | GomSpace Group AB: GomSpace signs 7.6 MEUR contract with VirtuaLabs for a satellite cluster for Radio Frequency space-based environment monitoring | GomSpace has signed a contract valued at 7.6 MEUR (81.5 MSEK) with VirtuaLabs, an Italy-based company specialized in Satellite Payloads, to deliver a cluster of satellites supporting space-based Radio... ► Artikel lesen | |
| ONTO INNOVATION | 170,00 | -5,56 % | ONTO INNOVATION INC. - 10-K, Annual Report | ||
| KOPIN | 2,000 | +0,15 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| ZENTEK | 0,545 | -3,54 % | Zentek Ltd.: Zentek Announces Pilot Evaluation Program with Quality Filters Inc. | GUELPH, ON / ACCESS Newswire / March 4, 2026 / Zentek Ltd. ("Zentek" or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) is pleased to announce the initiation of a pilot evaluation program with Quality Filters... ► Artikel lesen | |
| OBDUCAT | 0,005 | +56,25 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| SOLESENCE | 1,170 | -0,85 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| RIBER | 5,890 | -4,69 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| GAUZY | 0,495 | -4,25 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| ACACIA RESEARCH | 3,520 | +1,73 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 58,00 | -1,69 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,515 | 0,00 % | ADVANCE ZINCTEK LIMITED: Half Yearly Report and Accounts | ||
| LAMPETIA | 0,094 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOVIRICIDES | 0,740 | +2,78 % | MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| REGION GROUP | 1,315 | -0,03 % | REGION GROUP: Update - Notification of buy-back - RGN |